Reissland, M.* et al. Correction: USP10 drives cancer stemness and enables super-competitor signalling in colorectal cancer. Oncogene 44:336 (2025)
Ehrhardt, H.* et al. Editorial Expression of Concern: Cytotoxic drug-induced, p53-mediated upregulation of caspase-8 in tumor cells (Oncogene, (2008), 27, 6, (783-793), 10.1038/sj.onc.1210666). Oncogene, DOI: 10.1038/s41388-024-03093-2 (2024)
Reissland, M.* et al. USP10 drives cancer stemness and enables super-competitor signalling in colorectal cancer. Oncogene, DOI: 10.1038/s41388-024-03141-x (2024)
Tapmeier, T.T.* et al. Evolving polarisation of infiltrating and alveolar macrophages in the lung during metastatic progression of melanoma suggests CCR1 as a therapeutic target. Oncogene 41, 5032–5045 (2022)
Cebrià-Costa, J.P.* et al. LOXL2-mediated H3K4 oxidation reduces chromatin accessibility in triple-negative breast cancer cells. Oncogene 39, 79-121 (2020)
Redondo Monte, E.* et al. ZBTB7A prevents RUNX1-RUNX1T1-dependent clonal expansion of human hematopoietic stem and progenitor cells. Oncogene 39, 3195–3205 (2020)
Orth, M. ; Unger, K. ; Schoetz, U. ; Belka, C. & Lauber, K. Taxane-mediated radiosensitization derives from chromosomal missegregation on tripolar mitotic spindles orchestrated by AURKA and TPX2. Oncogene 37, 52-62 (2018)
Wang, X.* et al. Insulin resistance in vascular endothelial cells promotes intestinal tumour formation. Oncogene 36, 4987-4996 (2017)
Berscheminski, J.* et al. Sp100A is a tumor suppressor that activates p53-dependent transcription and counteracts E1A/E1B-55K-mediated transformation. Oncogene 35, 3178-3189 (2016)
Bognar, M. et al. Oncogenic CARMA1 couples NF-κB and β-catenin signaling in diffuse large B-cell lymphomas. Oncogene 35, 4269-4281 (2016)
Nowicka, A.M.* et al. A novel pVHL-independent but NEMO-driven pathway in renal cancer promotes HIF stabilization. Oncogene 35, 3125-3138 (2016)
Wimmer, P.* et al. PML isoforms IV and V contribute to adenovirus-mediated oncogenic transformation by functionally inhibiting the tumor-suppressor p53. Oncogene 35, 69–82 (2016)
Baumgart, A.* et al. Opposing role of Notch1 and Notch2 in a KrasG12D-driven murine non-small cell lung cancer model. Oncogene 34, 578–588 (2015)
O'Flanagan, C.H.* ; Morais, V.A.* ; Wurst, W. ; de Strooper, B.* & O'Neill, C.* The Parkinson's gene PINK1 regulates cell cycle progression and promotes cancer-associated phenotypes. Oncogene 34, 1363-1374 (2015)
Selmansberger, M.* et al. CLIP2 as radiation biomarker in papillary thyroid carcinoma. Oncogene 34, 3917-3925 (2015)
Nagel, D. ; Vincendeau, M. ; Eitelhuber, A.C. & Krappmann, D. Mechanisms and consequences of constitutive NF-κB activation in B-cell lymphoid malignancies. Oncogene 33, 5655-5665 (2014)
Vereide, D.T.* et al. Epstein-Barr virus maintains lymphomas via its miRNAs. Oncogene 44, 1258-1264 (2014)
Borsig, L.* ; Wolf, M.J.* ; Roblek, M.* ; Lorentzen, A.R. & Heikenwälder, M. Inflammatory chemokines and metastasis - tracing the accessory. Oncogene 33, 3217-3224 (2013)
Chaves-Perez, A. et al. EpCAM regulates cell cycle progression via control of cyclin D1 expression. Oncogene 32, 641-650 (2013)
Eißmann, M.* et al. Overexpression of the anti-apoptotic protein AVEN contributes to increased malignancy in hematopoietic neoplasms. Oncogene 32, 2586–2591 (2013)
Köchert, K.* et al. High-level expression of Mastermind-like 2 contributes to aberrant activation of the NOTCH signaling pathway in human lymphomas. Oncogene 30, 1831-1840 (2011)
Tanori, M.* et al. Opposite modifying effects of HR and NHEJ deficiency on cancer risk in Ptc1 heterozygous mouse cerebellum. Oncogene 30, 4740-4749 (2011)
Scheller, H. et al. c-Myc overexpression promotes a germinal center-like program in Burkitt's lymphoma. Oncogene 29, 888-897 (2010)
Wolf, M.J.* ; Seleznik, G.M.* ; Zeller, N.* & Heikenwälder, M. The unexpected role of lymphotoxin β receptor signaling in carcinogenesis: From lymphoid tissue formation to liver and prostate cancer development. Oncogene 29, 5006-5018 (2010)
Banjac, A. et al. The cystine/cysteine cycle: A redox cycle regulating susceptibility versus resistance to cell death. Oncogene 27, 1618-1628 (2008)
Ehrhardt, H.* et al. Cytotoxic drug-induced, p53-mediated upregulation of caspase-8 in tumor cells. Oncogene 27, 783-793 (2008)
Engelmann, A.* ; Speidel, D.* ; Bornkamm, G.W. ; Deppert, W.* & Stocking, C.* Gadd45β is a pro-survival factor associated with stress-resistant tumors. Oncogene 27, 1429-1438 (2008)
Greif, P.A. ; Tizazu, B.* ; Krause, A.J. ; Kremmer, E. & Bohlander, S.K. The leukemogenic CALM/AF10 fusion protein alters the subcellular localization of the lymphoid regulator Ikaros. Oncogene 27, 2886-2896 (2008)
Härtl, B.* ; Zeller, T.* ; Blanchette, P.* ; Kremmer, E. & Dobner, T.* Adenovirus type 5 early region 1B 55-kDa oncoprotein can promote cell transformation by a mechanism independent from blocking p53-activated transcription. Oncogene 27, 3673-3684 (2008)
Unger, K. et al. Array CGH demonstrates characteristic aberration signatures in human papillary thyroid carcinomas governed by RET/PTC. Oncogene 27, 4592-4602 (2008)
Hausherr, A. et al. Inhibition of IL-6-dependent growth of myeloma cells by an acidic peptide repressing the gp130-mediated activation of Src family kinases. Oncogene 26, 4987-4998 (2007)
Thirunarayanan, N.* et al. Enhanced tumorigenicity of fibroblasts transformed with human herpesvirus 8 chemokine receptor vGPCR by successive passage in nude and immunocompetent mice. Oncogene 26, 5702-5712 (2007)
Trivedi, A.K.* et al. Proteomic identification of C/EBP-DBD multiprotein complex: JNK1 activates stem cell regulator C/EBPalpha by inhibiting its ubiquitination. Oncogene 26, 1789-1801 (2007)
Djafarzadeh, R.* et al. GPI-anchored TIMP-1 treatment renders renal cell carcinoma sensitive to FAS-mediated killing. Oncogene 25, 1496-1508 (2006)
Dolznig Grebien, F.* et al. Erythroid progenitor renewal versus differentiation: Genetic evidence for cell autonomous, essential functions of EpoR, STat5 and the GR. Oncogene 25, 2890-2900 (2006)
Fröhlich Archangelo, L.* ; Gläsner, J.* ; Krause, A.* & Bohlander, S.K. The novel CALM interactor CATS influences the subcellular localization of the leukemogenic fusion protein CALM/AF10. Oncogene 25, 4099-4109 (2006)
Pazzaglia, S.* et al. Linking DNA damage to medulloblastoma tumorigenesis in patched heterozygous knockout mice. Oncogene 25, 1165-1173 (2006)
Dirmeier, U. et al. Latent membrane protein 1 of Epstein-Barr virus coordinately regulates proliferation with control of apoptosis. Oncogene 24, 1711-1717 (2005)
Weiss, C.* et al. TCDD induces c-jun expression via a novel Ah (dioxin) receptor-mediated p38-MAPK-dependent pathway. Oncogene 24, 4975-4983 (2005)
Yu, M.* et al. PARP-10, a novel Myc-interacting protein with poly(ADP-ribose) polymerase activity, inhibits transformation. Oncogene 24, 1982-1993 (2005)
Kappler, R.* et al. Profiling the molecular difference between Patched- and p53-dependent rhabdomyosarcoma. Oncogene 23, 8785-8795 (2004)
Münz, M. et al. The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation. Oncogene 23, 5748-5758 (2004)
Schlosser, I. et al. Dissection of transcriptional programmes in response to serum and c-Myc in a human B-cell line. Oncogene 24, 1-5 (2004)
Elsässer, A. et al. The fusion protein AML1-ETO in acute myeloid leukemia with translocation t(8;21) induces c-jun protein expression via the proximal AP-1 site of the c-jun promoter in an indirect, JNK-dependent manner. Oncogene 22, 5646-57 (2003)
Rangiata, J.* et al. Elevated c-Jun expression in acute myeloid leukemias inhibits C/EBPalpha DNA binding via leucine zipper domain interaction.  Oncogene 22, 4760-4764 (2003)
Zada, A.A.P.* et al. Downregulation of c-Jun expression and cell cycle regulatory molecules in acute myeloid leukemia cells upon CD44 ligation.  Oncogene 22, 2296-2308 (2003)
Nathrath, M. et al. Two novel tumor suppressor gene loci on chromosome 6q and 15q in human osteosarcoma identified through comparative study of allelic imbalances in mouse and man. Oncogene 21, 5975-5980 (2002)
Pazzaglia, S.* et al. High incidence of medulloblastoma following X-ray-irradiation of newborn Ptc1 heterozygous mice. Oncogene 21, 7580-7584 (2002)
Vecsey-Semjen, B.* et al. Novel colon cancer cell lines leading to better understanding of the diversity of respective  primary cancers. Oncogene 21, 4646-4662 (2002)
Lewitzky, M.* et al. The C-terminal SH3 domain of the adapter protein Grb2 binds with high affinity to sequences in Gab1 and SlP-76 which lack the SH3-typical P-x-x-P core motif. Oncogene 20, 1052-1062 (2001)
Boese, A.* et al. Human endogenous retrovirus protein cORF supports cell transformation and associated with the promyelocytic leukemia zinc finger protein. Oncogene 19, 4328-4336 (2000)
Zimmermann, S.* et al. MEK1 mediates a positive feedback on Raf-1 activity independently of Ras and Src. Oncogene 15, 1503-1511 (1997)
Mautner, J. et al. c-myc expression is activated by the immunoglobulin kappa-enhancers from a distance of at least 30 kb but not by elements located within 50 kb of the unaltered c-myc locus in vivo. Oncogene 12, 1299-1307 (1996)
Albert, T.K. ; Urlbauer, B. ; Kohlhuber, F. ; Hammersen, B. & Eick, D. Ongoing mutations in the N-terminal domain of c-Myc affect transactivation in Burkitt's lymphoma cell lines. Oncogene 9, 759-763 (1994)
Kohlhuber, F. ; Strobl, L.J. & Eick, D. Early down-regulation of c-myc in dimethylsulfoxide-induced mouse erythroleukemia (MEL) cells is mediated at the P1/P2 promoters. Oncogene 8, 1099-1102 (1993)
Rößler, U. ; Andres, A.C.* ; Reichmann, E.* ; Schmahl, W.G. & Werenskiold, A.K. T1, an immunoglobulin superfamily member, is expressed in H-ras-dependent epithelial tumours of mammary cells. Oncogene 8, 609-617 (1993)
Apel, T.W. ; Mautner, J.M. ; Polack, A. ; Bornkamm, G.W. & Eick, D. Two antisense promoters in the immunoglobulin μ-switch region drive expression of c-myc in the Burkitt's lymphoma cell line BL67. Oncogene 7, 1267-1271 (1992)
Jucker, M. et al. Expression of Truncated Transcripts of the Proto-Oncogene c-fps/fes in Human Lymphoma and  Lymphoid Leukemia Cell Lines. Oncogene 7, 943-952 (1992)
Polack, A. et al. The Intron Enhancer of the Immunoglobulin Kappa Gene Activates c-myc but does not Induce the Burkitt-Specific Promoter Shift. Oncogene 6, 2033-2040 (1991)
Eick, D. et al. Expression of P0-and P3-RNA from the Normal and Translocated c-myc Allele in Burkitt's  Lymphoma Cells. Oncogene 5, 1397-1402 (1990)